Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q4 FY26 results · Jan–Mar 2026
Divi's Laboratories reported revenue from operations of ₹2,831.00 crore (up 9.5% from Q4 FY25) and net profit of ₹751.00 crore (up 13.4% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,831.00 | 2,585.00 | +9.5% | 2,604.00 | +8.7% |
| Other income | 155.00 | 86.00 | +80.2% | 88.00 | +76.1% |
| Total income | 2,986.00 | 2,671.00 | +11.8% | 2,692.00 | +10.9% |
| Profit before tax | 963.00 | 864.00 | +11.5% | 780.00 | +23.5% |
| Net profit for the period | 751.00 | 662.00 | +13.4% | 583.00 | +28.8% |
| EPS, basic (₹) | 28.31 | 24.93 | +13.6% | 21.98 | +28.8% |
| Net margin (%) | 26.5 | 25.6 | 22.4 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,793.00 | 2,536.00 | +10.1% | 2,578.00 | +8.3% |
| Other income | 154.00 | 87.00 | +77.0% | 87.00 | +77.0% |
| Total income | 2,947.00 | 2,623.00 | +12.4% | 2,665.00 | +10.6% |
| Profit before tax | 971.00 | 861.00 | +12.8% | 798.00 | +21.7% |
| Net profit for the period | 756.00 | 667.00 | +13.3% | 598.00 | +26.4% |
| EPS, basic (₹) | 28.44 | 25.12 | +13.2% | 22.56 | +26.1% |
| Net margin (%) | 27.1 | 26.3 | 23.2 |
Consolidated
- Filed with BSE
- 27 May 2026, 17:30 IST
- Board meeting
- 23 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2026, 17:30 IST
- Board meeting
- 23 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE